Pretax income is the income that a company earns before paying income taxes. Dermira's pretax income for the
three
months ended in Sep. 2019 was $-57.62 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2019 was $-212.23 Mil.
Dermira's pretax margin was -499.62%.
Dermira Pre-Tax Income Historical Data
The historical data trend for Dermira's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dermira's Pre-Tax Income
For the Biotechnology subindustry, Dermira's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermira's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dermira's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Dermira's Pre-Tax Income falls into.
Dermira Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Dermira's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-212.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermira (NAS:DERM) Pre-Tax Income Explanation
Dermira's Pretax Margin for the quarter that ended in Sep. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermira Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Dermira's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Dermira Inc is a biopharmaceutical company focuses on the development and commercialization of medical dermatology products to dermatologists and their patients primarily in the United States.The company's late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DERM has been successfully added to your 